Loading…
Oncolytics Biotech Inc. is projected to rise to $1.20 by 2027, a +34% move from its current price of $0.90. ONCY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.8646 | $0.8996 | $0.936 | -0.05% |
| May 30 | $0.8501 | $0.8992 | $0.9511 | -0.09% |
| May 31 | $0.839 | $0.8988 | $0.9627 | -0.14% |
| Jun 1 | $0.8298 | $0.8983 | $0.9726 | -0.18% |
| Jun 2 | $0.8217 | $0.8979 | $0.9813 | -0.23% |
| Jun 3 | $0.8143 | $0.8975 | $0.9892 | -0.28% |
| Jun 4 | $0.8077 | $0.8971 | $0.9964 | -0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8077 | $0.8971 | $0.9964 | -0.32% |
| Week 2 | $0.7708 | $0.8942 | $1.04 | -0.64% |
| Week 3 | $0.7431 | $0.8913 | $1.07 | -0.96% |
| Week 4 | $0.7201 | $0.8884 | $1.10 | -1.28% |
| Week 5 | $0.7002 | $0.8856 | $1.12 | -1.60% |
| Week 6 | $0.6825 | $0.8827 | $1.14 | -1.92% |
| Week 7 | $0.6664 | $0.8799 | $1.16 | -2.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company focused on oncology, developing pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (GI) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer.
It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies.
Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Oncolytics Biotech Inc. (ONCY) operates in the Healthcare sector. Its current price is $0.90 and its market cap is $107.42M, with a ranking of 4150.
The forecast implies a generally bullish price trajectory after 2026, beginning with a neutral 2026 and turning bullish in 2027 through 2050.
Longer-horizon projections show upside, including a 2050 maximum forecast of $8.81 and a 2050 average forecast around $4.07, reflecting meaningful potential upside over time.
A major floor 36.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.3% below — buyers have tended to step in here.
The nearest ceiling, 27.8% above — a clean break opens room to run.
A major ceiling 45.9% above — clearing it would confirm fresh momentum.
Key ONCY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ONCY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.826 | Buy | $0.8408 | Buy |
| MA 10 | $0.83 | Buy | $0.8428 | Buy |
| MA 20 | $0.864 | Buy | $0.871 | Buy |
| MA 50 | $0.9344 | Sell | $0.9226 | Sell |
| MA 100 | $0.9727 | Sell | $0.9577 | Sell |
| MA 200 | $1.04 | Sell | $0.9708 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.47 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 61.86 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 1.12 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.62 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 53.48 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.83 | Buy |
| ADX (14) | 17.79 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50.
The 50-day moving average is $0.9344 and the 200-day moving average is $1.04, with near-term support at $0.78 and resistance at $1.15.
The 30-day price range runs from $0.6928 to $1.17, and the asset shows annualized volatility of 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.78 | $0.90 | $1.21 | 0% | Neutral | |
| $0.9132 | $1.20 | $1.70 | +34% | Bullish | |
| $0.8816 | $1.21 | $1.80 | +35% | Bullish | |
| $0.8919 | $1.27 | $1.96 | +41% | Bullish | |
| $0.8429 | $1.24 | $1.97 | +38% | Bullish | |
| $0.7946 | $1.20 | $1.97 | +34% | Bullish | |
| $0.9494 | $1.48 | $2.48 | +64% | Bullish | |
| $1.04 | $1.66 | $2.86 | +85% | Bullish | |
| $1.13 | $1.85 | $3.25 | +106% | Bullish | |
| $1.25 | $2.09 | $3.74 | +132% | Bullish | |
| $1.55 | $2.91 | $5.62 | +223% | Bullish | |
| $1.83 | $4.07 | $8.81 | +353% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.78 | $0.90 | $1.06 | +0.00% |
| June 2026 | $0.7381 | $0.8754 | $1.07 | -2.73% |
| July 2026 | $0.7186 | $0.8629 | $1.07 | -1.43% |
| August 2026 | $0.7369 | $0.8935 | $1.13 | +3.55% |
| September 2026 | $0.7205 | $0.8807 | $1.13 | -1.44% |
| October 2026 | $0.6829 | $0.841 | $1.09 | -4.50% |
| November 2026 | $0.7005 | $0.8683 | $1.13 | +3.25% |
| December 2026 | $0.7378 | $0.9204 | $1.21 | +5.99% |
Click any year to see its month-by-month ONCY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ONCY is projected to trade between $0.78 and $1.21, averaging $0.90 — a potential gain of 0% from today's $0.90. Price action looks broadly range-bound.
Oncolytics Biotech Inc.'s 2027 outlook centres on $1.20, within a $0.9132 to $1.70 range. That is up +34% on the projected 2026 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ONCY could reach as high as $1.80, with a base case around $1.21 and support toward $0.8816 — roughly +35% from $0.90. Momentum favours further upside here.
Expect ONCY to range from $0.8919 to $1.96 through 2029. The $1.27 average target implies a +41% move from current prices. That is up +5% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ONCY price prediction for 2030 points to an average of $1.24 (low $0.8429, high $1.97) — a potential gain of +38% on today's $0.90. Momentum favours further upside here.
In 2031, ONCY is projected to trade between $0.7946 and $1.97, averaging $1.20 — a potential gain of +34% from today's $0.90. That is -3% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Oncolytics Biotech Inc.'s 2032 outlook centres on $1.48, within a $0.9494 to $2.48 range. That is up +23% on the projected 2031 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2033, ONCY could reach as high as $2.86, with a base case around $1.66 and support toward $1.04 — roughly +85% from $0.90. Buyers look set to stay in control over this stretch.
Expect ONCY to range from $1.13 to $3.25 through 2034. The $1.85 average target implies a +106% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The ONCY price prediction for 2035 points to an average of $2.09 (low $1.25, high $3.74) — a potential gain of +132% on today's $0.90. Buyers look set to stay in control over this stretch.
In 2040, ONCY is projected to trade between $1.55 and $5.62, averaging $2.91 — a potential gain of +223% from today's $0.90. That is up +39% on the projected 2035 average. Momentum favours further upside here.
Oncolytics Biotech Inc.'s 2050 outlook centres on $4.07, within a $1.83 to $8.81 range. That is up +40% on the projected 2040 average. That marks a +353% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ONCY today (≈ 1,111.111111 ONCY) could be worth
$4,526.47
+$3,526.47 (+353%) by 2050 · US Dollar
Based on the average projected ONCY price of $4.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ONCYwould be worth at today's price.
$1,000 invested in ONCY on May 27, 2025 (≈ 2,499.999963 ONCY) would be worth
$2,250
+$1,250 (+125.0%) today · 2.25× · US Dollar
Based on a ONCY entry price of $0.4 vs. today's $0.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.82 | $1,097.56 | +9.8% |
| 1 month ago | $0.97 | $927.84 | -7.2% |
| 3 months ago | $1.07 | $841.12 | -15.9% |
| 6 months ago | $1 | $900 | -10.0% |
| 1 year ago | $0.4 | $2,250 | +125.0% |
| All time (5.0y) ago | $3.18 | $283.02 | -71.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ONCY forecast.
Our base-case forecast reaches $1.80 around 2034.
Implied market cap at $1.80: $214.84M
The multi-year forecast shows a bullish trend across the horizon, with 2026 starting neutral ($0.78 min, $0.90 avg, $1.21 max, ROI 0) and all subsequent years labeled BULLISH.
Key mid-term milestones include 2027 with an average of $1.20 and ROI 33.8%, 2028 with an average of $1.21 and ROI 34.7%, 2029 with an average of $1.27 and ROI 41.1%, and 2030 with an average of $1.24 and ROI 37.7%.
From 2031 onward, the forecast continues higher, with 2031 average $1.20 (ROI 33.6%), 2032 average $1.48 (ROI 64.1%), 2033 average $1.66 (ROI 84.8%), 2034 average $1.85 (ROI 106%), and 2035 average $2.09 (ROI 132.5%).
Further out, 2040 is forecast to average $2.91 (ROI 223.2%), and 2050 to average $4.07 (ROI 352.6%), with bullish sentiment across these long-horizon years.
Tap a question to reveal the answer.
Avg price $1.24, range $0.8429 to $1.97, ROI 37.7%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 through 2050, with ROIs of 33.8% (2027) through 352.6% (2050); 2026 is neutral. Current price is $0.90 and market cap is $107.42M.
Yes—the 2050 maximum forecast is $8.81, indicating potential upside within the projection.
Current price $0.90; market cap $107.42M; rank 4150.
Sentiment NEUTRAL; RSI14 50; SMA50 $0.9344; SMA200 $1.04; support $0.78; resistance $1.15; 30-day range $0.6928-$1.17; annualized volatility 80%.
Oncolytics Biotech Inc. Community Discussion
0Share your Oncolytics Biotech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.